热门资讯> 正文
ShockWave Medical 2024年第一季度盈利预览
2024-05-04 05:20
- ShockWave Medical (NASDAQ:SWAV) is scheduled to announce Q1 earnings results on Monday, May 6th, after market close.
- The consensus EPS Estimate is $0.93 (-9.7% Y/Y) and the consensus Revenue Estimate is $207.65M (+29.0% Y/Y).
- Over the last 2 years, SWAV has beaten EPS estimates 63% of the time and has beaten revenue estimates 88% of the time.
- Over the last 3 months, EPS estimates have seen 3 upward revisions and 2 downward. Revenue estimates have seen 5 upward revisions and 1 downward.
More on ShockWave Medical
- Why Shockwave Medical Stands Out In The Medical Device Sector
- Shockwave Medical Q4 Earnings Recap: Plenty Of Reasons To Stay Bullish
- Shockwave Medical: Opening Arteries, Delivering Returns
- Johnson & Johnson to acquire Shockwave Medical for $13.1B (update)
- J&J-Shockwave deal makes strategic sense: analysts
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
